RT @ArdenBarry: Unsurprising results of recent @JACCJournals meta-analysis of ASA for primary CV prevention: lower risk of MI but increased…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
RT @jvillacastin: Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Va…
Si quieres conocer la actualidad sobre la utilidad de la aspirina para prevenir eventos cardiovasculares, puedes oír a Valentín Fuster comentando este primer artículo de revisión en JACC. https://t.co/8VodI0jWMe https://t.co/apOCdYanjx
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @MarwanSaadMD: Aspirin for Primary Prevention of CV events @JACCJournals @JDawnAbbott1 @herbaronowMD @DLBHATTMD @MichaelMegalyMD @Kc_KrI…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/t40887kiTk
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/0gbru7r9KT
RT @ArdenBarry: Unsurprising results of recent @JACCJournals meta-analysis of ASA for primary CV prevention: lower risk of MI but increased…
RT @MarwanSaadMD: Aspirin for Primary Prevention of CV events @JACCJournals @JDawnAbbott1 @herbaronowMD @DLBHATTMD @MichaelMegalyMD @Kc_KrI…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/wkiee9MEjW
RT @MarwanSaadMD: Aspirin for Primary Prevention of CV events @JACCJournals @JDawnAbbott1 @herbaronowMD @DLBHATTMD @MichaelMegalyMD @Kc_KrI…
RT @ArdenBarry: Unsurprising results of recent @JACCJournals meta-analysis of ASA for primary CV prevention: lower risk of MI but increased…
Unsurprising results of recent @JACCJournals meta-analysis of ASA for primary CV prevention: lower risk of MI but increased risk of major bleeding (with high NNT/NNH) and no difference in death/cancer: https://t.co/bXUIMu5dEn https://t.co/HqCYHHj2Bj
RT @MarwanSaadMD: Aspirin for Primary Prevention of CV events @JACCJournals @JDawnAbbott1 @herbaronowMD @DLBHATTMD @MichaelMegalyMD @Kc_KrI…
Aspirin for Primary Prevention of CV events @JACCJournals @JDawnAbbott1 @herbaronowMD @DLBHATTMD @MichaelMegalyMD @Kc_KrIsChAn
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/oJYyopW8Hd
15 RCTs Meta/ 165,502 ppl. ASA vs control in Primary #CvPrev Benefit: nonfatal MI (RR: 0.82) TIA (RR: 0.79) ,ischemic stroke (RR: 0.87) Risk: major bleeding (RR: 1.5; 95% CI: 1.33 to 1.69) 1 more reason to use ASCVD Risk scores https://t.co/4gnHofGBxd h
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
RT @JACCJournals: #JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases non…
#JACC meta-analysis shows aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. https://t.co/yr5UwXOxC0 #cvPrev https://t.co/Hj9G2920i8
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @StefaniaArciell: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/qmo4majPB9
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/kdUbkQbZjF #accfit
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
@JACCJournals La aspirina para la prevención primaria reduce los eventos isquémicos no fatales, pero aumenta significativamente los eventos hemorrágicos Aspirin for Primary Prevention of Cardiovascular Events https://t.co/7zXrP63PGt https://t.co/yVlYl6I1be
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/qmo4majPB9
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
Aspirin for Primary Prevention of Cardiovascular Events | JACC: Journal of the American College of Cardiology https://t.co/kyFjZlAGMr
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
#Aspirina como prevención 1⃣reduce los eventos isquémicos no fatales pero incrementa signif. el sangrado no fatal. Via @JACCJournals 📌https://t.co/Aru4dScTVY @vic_pallares @medicosergio @mendez_bailon @IcyfaSemi @chemachir @zbestella @sandrapaulinarg @ern
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @FormigaFrancesc: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/s5SvYUNUVW
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…